Opioid Detoxification During Pregnancy: A Systematic Review
- PMID: 29630016
- PMCID: PMC6034119
- DOI: 10.1097/AOG.0000000000002562
Opioid Detoxification During Pregnancy: A Systematic Review
Abstract
Objective: To systematically review maternal and neonatal outcomes associated with opioid detoxification during pregnancy.
Data sources: PubMed, PsycINFO, EMBASE, Cochrane, and ClinicalTrials.gov databases were searched from January 1, 1966, to September 1, 2016.
Methods of study selection: English-language studies that reported outcomes associated with opioid detoxification among pregnant women with opioid use disorder were included. Nonoriginal research articles (case reports, editorials, reviews) and studies that failed to report outcomes for detoxification participants were excluded. Bias was assessed using the Cochrane Collaboration's tool for assessing risk of bias and quality was assessed using the U.S. Preventive Service Task Force Quality of Evidence scale.
Tabulation, integration, and results: Of 1,315 unique abstracts identified, 15 met criteria for inclusion and included 1,997 participants, of whom 1,126 underwent detoxification. Study quality ranged from fair to poor as a result of the lack of a randomized control or comparison arm and high risk of bias across all studies. Only nine studies had a comparison arm. Detoxification completion (9-100%) and illicit drug relapse (0-100%) rates varied widely across studies depending on whether data from participants who did not complete detoxification or who were lost to follow-up were included in analyses. The reported rate of fetal loss was similar among women who did (14 [1.2%]) and did not undergo detoxification (17 [2.0%]).
Conclusions: Evidence does not support detoxification as a recommended treatment intervention as a result of low detoxification completion rates, high rates of relapse, and limited data regarding the effect of detoxification on maternal and neonatal outcomes beyond delivery.
Conflict of interest statement
The authors did not report any potential conflicts of interest.
Figures
Comment in
-
Opioid Detoxification During Pregnancy: A Systematic Review.Obstet Gynecol. 2018 Oct;132(4):1061. doi: 10.1097/AOG.0000000000002886. Obstet Gynecol. 2018. PMID: 30247339 No abstract available.
-
In Reply.Obstet Gynecol. 2018 Oct;132(4):1061-1062. doi: 10.1097/AOG.0000000000002885. Obstet Gynecol. 2018. PMID: 30247340 No abstract available.
References
-
- American Society of Addiction Medicine (ASAM) National practice guideline for the use of medications in the treatment of addiction involving opioid use. Available at: https://www.asam.org/docs/default-source/practice-support/guidelines-and.... Retrieved January 26, 2018. - PMC - PubMed
-
- World Health Organization (WHO) Community management of opioid overdose. Available at: http://apps.who.int/iris/bit-stream/10665/137462/1/9789241548816_eng.pdf. Retrieved January 26, 2018.
-
- Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2017;130:e81–94. - PubMed
-
- Rementeriá JL, Nunag NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol. 1973;116:1152–6. - PubMed
-
- Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol. 1975;122:43–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
